Faron Pharmaceuticals
0.51 EUR
-2.88 %
5,682 following
Corporate customer
FARON
First North Finland
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Dividend
Investor consensus
Valuation
Income statement
Quarterly estimates
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Faron Pharmaceuticals
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.1 |
| growth-% | 26,221.6 % | ||||||||||
| EBITDA | -12.9 | -16.4 | -20.8 | -27.4 | -28.2 | -18.3 | -18.8 | -18.7 | -24.8 | -25.4 | -13.6 |
| EBIT (adj.) | -13.1 | -16.7 | -21.1 | -27.4 | -28.6 | -18.7 | -19.0 | -19.0 | -25.0 | -25.6 | -13.7 |
| EBIT | -13.1 | -16.7 | -21.1 | -27.4 | -28.6 | -18.7 | -19.0 | -19.0 | -25.0 | -25.6 | -13.7 |
| Profit before taxes | -13.3 | -16.9 | -21.2 | -28.7 | -30.9 | -26.0 | -27.3 | -23.0 | -27.0 | -26.6 | -14.7 |
| Net income | -13.3 | -16.9 | -21.2 | -28.6 | -30.9 | -25.9 | -27.3 | -23.0 | -27.0 | -26.6 | -14.7 |
| EPS (adj.) | -0.31 | -0.36 | -0.40 | -0.48 | -0.45 | -0.25 | -0.23 | -0.10 | -0.11 | -0.10 | -0.06 |
| growth-% | |||||||||||
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EBITDA-% | -321,575.0 % | -409,275.0 % | -520,050.0 % | -685,675.0 % | -705,550.0 % | -456,750.0 % | -469,000.0 % | -467,500.0 % | -619,770.0 % | -635,065.0 % | -1,290.2 % |
| EBIT-% (adj.) | -327,525.0 % | -416,350.0 % | -527,700.0 % | -685,650.0 % | -714,200.0 % | -466,750.0 % | -474,000.0 % | -475,000.0 % | -625,000.0 % | -639,250.0 % | -1,302.9 % |
| EBIT-% | -327,525.0 % | -416,350.0 % | -527,700.0 % | -685,650.0 % | -714,200.0 % | -466,750.0 % | -474,000.0 % | -475,000.0 % | -625,000.0 % | -639,250.0 % | -1,302.9 % |
| ROE | 14,063.1 % | -3,920.3 % | 670.4 % | 232.3 % | 207.8 % | 192.7 % | 266.9 % | 374.2 % | 110.7 % | 37.1 % | |
| ROI | -676.3 % | -588.9 % | -707.3 % | 7,250.8 % | 16,449.3 % | -474.4 % | -102.0 % | -140.6 % | -1,731.5 % | 2,306.0 % |